STAT | Reporting from the frontiers of health and medicine Follow STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more AstraZeneca disclosed that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors https://www.statnews.com/pharmalot/2026/09/14/another-astrazeneca-trial-failure-novo-name-change/ statnews.com
